Venture capital is investing little in new treatment for addiction, report finds
There are about as many Americans living with addiction as there are Americans living with cancer — but you wouldn’t know it based on the world of venture capital.
In the past decade, investment firms have poured roughly 270 times more money into developing cancer drugs than addiction cures, according to a new report from BIO, the biotechnology industry trade group.
